A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
Conditions: Systemic Lupus Erythematosus; Cutaneous Lupus Erythematosus; Sjogren's Syndrome; Systemic Sclerosis; Polymyositis; Dermatomyositis Interventions: Drug: VIB7734; Drug: Placebo Sponsor: Viela Bio Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dermatology | Dermatomyositis | Lupus | Polymyositis | Research | Scleroderma | Sjogren's Syndrome | Study